------ =_NextPart_000_01BCBF85.8E713270
Content-Type: text/plain;
charset="iso-8859-1"
This is unexpected and scary,if true...
-- Russell Whitaker Webmaster, AlphaBlox Corporation http://www.alphablox.com/ ============================== "Living in a bookshop is like living in a warehouse of explosives. Those shelves are ranked with the most furious combustibles in the world - the brains of men." - Christopher Morley> -----Original Message----- > From: FDVanArdoy@aol.com [SMTP:FDVanArdoy@aol.com] > Sent: Friday, September 12, 1997 11:32 AM > To: Russell Whitaker > Subject: Fwd: Codex Alimentarius - A Plan To Ban All Food > Supplements > > > --------------------- > Forwarded message: > From: ewin@acm.org (Ewin H. Barnett) > Sender: Missouri_Libertarians@safe.chem.missouri.edu > Reply-to: Missouri_Libertarians@safe.chem.missouri.edu > To: Missouri_Libertarians@safe.chem.missouri.edu (Multiple > recipients of) > Date: 97-09-12 08:32:22 EDT > > To send a message to this list, use this address: > molp@safe.chem.missouri.edu > > To send commands (like "help" or "unsubscribe Missouri_Libertarians") > to the > server that hosts this list, use this address: > macjordomo@safe.chem.missouri.edu > > Subject: > Codex Alimentarius - A Plan To Ban All Supplements > Date: > Thu, 11 Sep 97 21:20:53 -0600 > From: > Ben & Ally Maddox <alm@cheerful.com> > > > > Dear Friend - > > Below is a well written account of what the CODEX Alimentarius > Commission > will mean to every American, Canadian and European. Please read and > stop > > Bill S.830. Write to your Congressman, Senator and local newspapers, > and > > tell all your friends. > ___________________________________________________________________ > > > Codex Alimentarius - A Plan To Ban All Supplements > By Jackie Buchanan > > > "Unless we put medical freedom into the constitution, the time > will come when medicine will organize itself into an undercover > dictatorship...denying equal privileges. All such laws are un- > American and despotic... > > -Benjamin Rush, Physician > Signer, Declaration of Independence > > > Codex Alimentarius, in simple terms, is a code of law for food. > What it actually means to each and everyone of us is a threat to our > health and the health of every human being on this planet. > > The future availability and legal status of herbs, vitamins, > amino acids, minerals and all other supplements in the U.S. and > throughout the world, may be determined by a committee made up of 146 > nations called the Codex Alimentarius Commission, which operates in > conjunction with the United Nations and the World Health Organization > (WHO). > > It is under the guise of protecting public safety through the > standardization of food and botanical codes that the commission > may be a tool of the international pharmaceutical industry that > is intent on making ALL SUPPLEMENTS -herbal or otherwise- > available by prescription only. > > Established in 1962 for the purpose of setting international > standards and codes for foods, the Codex Commission is over- > whelmingly composed of German and International Pharmaceutical > Corporations. Over 90% of the international organizations ALLOWED to > send delegates to the meetings represent giant multinational > pharmaceutical corporations. The only consumer organization is the > International Organization of Consumer Unions. NEITHER THE NATURAL > HEALTH CARE INDUSTRY NOR THE GENERAL PUBLIC HAS ANY > REPRESENTATION AT THE CODEX MEETINGS. > > Spearheaded by the German pharmaceutical corporations, this > Codex Commission plans to ban -on a worldwide basis- any health > statement in relation to any non-prescription supplement, > preventive, therapeutic, or otherwise. Moreover, any formulas > which would still be available would have to meet the arbitrary > restrictions of the Codex Commission. Those nations that do not comply > with these restrictions are faced with economic sanctions. > > While researching this article, I came across a letter written > in 1995 from Matthias Rath,MD to Chancellor Kohl and Members of > the German Bundersag, prior to the Codex meeting in Bonn Germany > in 1996. > > "As a physician and scientist who led the breakthrough in > vitamin research which can eradicate heart disease, I feel > it is incumbent upon me to address this important matter... > as I see it, the attack of the Codex Commission is a > desperate act by the pharmaceutical companies to protect > their world wide drug market against naturally effective > and much more affordable supplements. Particularly disturbing is > the role of the German pharmaceutical and chemical corporations > within the Codex Commission. Once before in this century, a > German pharmaceutical and chemical corporation, I.G. Farben, > became responsible for the deaths of millions of people and > consequently was dismantled in 1946 by the Nurenberg Tribunal and > split into Bayer, BASF, and Hoechst. With the current plans of > the German pharmaceutical companies, the predictable dimension of > the unnecessary and premature death of millions of people is > unavoidable. If the Codex Commission is allowed to obstruct the > eradication of heart disease by restricting access to nutritional > supplements, more than 12 million people world-wide will continue > to die every year from premature heart attacks and strokes. > Within the next generation alone, this would result in over 300 > million premature deaths, more than in all the wars of mankind > together..." > > When I first read this, I took it with a grain of salt - until I > came across an article in Issue 14 of the Alternative Medicine > Digest, a reprint of an article that originally appeared in the > Wall Street Journal on April 25, 1996. The headline read "They're > Scientific When It Suits Them, But a $1.4-Billion Deal is Better than > Science." The article opened by saying that if a study which was > peer-reviewed by 5 independent medical experts had been published in > the Journal of the American Medical Association in January 1995 as > planned, American consumers with thyroid problems would have saved > $356 million a year in drug costs. > > However, the publication of this article would have wrecked > a $1.4-billion deal for its manufacturer, Boots Company, the > British pharmaceuticals and drugstore chain. The study documented > how Synthroid, which controls 84% of the US thyroid medication > market and is used by 8 million Americans, works no better than 3 > other lower priced drugs. > > The makers of Synthroid - first introduced in 1958 as a > synthetic version of thyroid hormone - had never been > required by the FDA to submit proper clinical trial data, > like other drugs. An unpatented drug for underactive > thyroids,Synthroid's vigorous U.S. sales have been protected > by something as good as a patent: the presumption that the > competing, lower-priced drugs are not bioequivalent, which means > that they are not absorbed and assimilated as fast and as well as > Synthroid. > > The JAMA study proved this presumption wrong and it was about to > call an end to Synthroid's free market run. Even worse, the study > would have jeopardized Boots' $1.4 billion buy-out by Germany's > BASF-AG. How did the study's sponsor, which has invested $250,000 > to finance the research feel about it? It was the sponsor itself > -- none other than Boots that did everything to discredit the > study and block its publication. Quite clearly, scientific > evidence takes a backseat to preserving the competitive edge. > > Another more recent web-site written from a Canadian point of > view about how Codex will affect Canada goes on to state: > > In October, 1996, Codex met in Bonn, Germany to make radical > changes in the rules governing dietary supplements for member > nations. The proposals of greatest concern were those > made by the German delegation (see the proposed Draft Guidelines > for Dietary Supplements) and is being sponsored by Hoechst, Bayer > and BASF. These are the three drug companies formed when the > Nurenberg War Trials disbanded IG Farben, manufacturer of > the poison gas used in Nazi concentration camps. This is not the > first time that the UN has been linked closely with Nazi war > criminals. Ostensibly, their purpose is "...to create a > set of international standards to guide the world's growing food > industry and to protect the health of consumers. > > Can reports from 4 different, totally unrelated sources, be > ignored? I think not! > > The pharmaceutical company backed proposals call for the following: > > 1. No vitamin, mineral, herb, etc., can be sold for > prophylactic (preventative) or therapeutic reasons. > > 2. Natural remedies can be sold as food but they must not exceed > the potency (dosage) levels set by the commission. This means > that consumer access to dietary supplements will be limited to > the RDA dosage as a maximum limit for vitamins (Vitamin C - 60 > mg. Vitamin E - 15 mg., etc.) Supplements without an RDA (e.g. > coenzyme Q10) would be illegal to sell because they would all > become drugs. > > 3. Codex regulations for dietary supplements would become > binding, eliminating the escape clause within the General > Agreement of Tariffs and Trade (GATT) that allows a nation > to set its own standards. This applies to all member > countries of the UN. Any nation that does not accept these > new standards will be heavily fined by the World Trade > Organization (WTO) creating the potential for crippling > entire sectors of that nation's economy. > > 4. All new supplements would be banned unless they go through > the Codex approval process. Five steps have already been > taken in the Codex process over the past few years. Remember > Canadian Bill C-7 which was passed eventually in Canada as C-8? > The similarity of the process, the secrecy, and the wording > between the Codex proposals and the Canadian laws is uncanny. > Voting in favor of adopting the German proposals has been > overwhelming (16 for 2 against in the most recent vote). The > Codex process is now at Step Five - formalization and debate > concerning the specific features. In two years, Codex could jump > from Step 5 to Step 8 to finalize these restrictions. > > In the U.S., the FDA has already tried to use guerrilla tactics to > stop the use of these supplements. The first time I became totally > aware of their horrendous practices was in the case of ESSIAC, the > herbal formula that had been researched since the 1920's with > excellent results in curing, yes I said curing, cancer. Fortunately, > once their tactics came to light, a nation-wide non-violent revolution > took place resulting in millions who were appalled at the tactics, > writing letters and calling their congressmen and the FDA. The end > result, ESSIAC is now widely available in many forms. Even Respirin, > the drug company in Canada who owned the rights to the formula has > started producing it and selling it via magazine ads and in health > food stores. All of this took place in 1989-1990. > > In 1992, the FDA raided the Tahoma Clinic in Kent, Washington. The > FDA alleged that Dr. Wright, MD was engaged in the commerce of foreign > labeled injectable "drugs" (which were actually vitamins). This action > interfaced with FDA raids of 17 health food stores in Texas and others > in Oklahoma, supplement manufacturing facilities in California, > Oregon, and Washington, and other nutritionally-oriented medical > doctors across the US. Again, there was a national call to action of > everyone interested in preserving their rights to make their own > choices in health care. Letters were mailed and faxed to the White > House by the millions and once again, the FDA was forced to back off. > At this same time Bill H.R. 3642/S2135 was in committee and being > reviewed prior to voting it into law. This bill would have given the > FDA the power to put the health food and dietary supplement industry > out of business. It would have also given them the power to legally > conduct warrantless searches, seize and embargo products and levy > heavy fines ($250,000 on individuals and $1,000,000 on companies) > without a trial. Again, the people of the United States took action > and through a powerful campaign whereby they voiced their opinions, > another small battle was won for freedom of choice! > > In 1995, the FDA attempted to quietly but quickly do away with > the use of any type of electronic instrumentation (not already > approved) for use in diagnosing, tracking, or treating illness. > This would have affected many doctors, dentists, osteopathic > physicians, chiropractors, etc. Fortunately, they banded together, got > their scientific studies and documentation together and, after a long > hard struggle, managed to hold their ground and prevent the FDA and > other interested parties (pharmaceutical companies and medical > practitioners who felt that only the usual methods of treatment, ie. > surgery and drugs should be allowed) from getting their way. > > Now, here we are in 1997 and BY ALL APPEARANCES, the FDA has > ceased their efforts to take away our rights to make our own > choices about healthcare. Their policy with regard to the Codex > standards is stated in the Federal Register of October 11, 1995 > - FDA Policy on Standards, which states: > > "It is the intent of this policy to enable the FDA to continue > to participate in international standards activities that assist > it in implementing statutory provisions... > > and > > "The development of an international standard that achieves the > agency's public objectives is generally, but not always, given a > higher priority than the development of a domestic standard... > > and > > "Where a relevant international standard exists, or completion > is imminent, it will generally be used in preference to a domestic > standard... > > In considering the above statements about their intentions coupled > with their past tactics as well as their continuing policy of ignoring > the public's wishes in protecting health freedom, a public outcry > against the Codex is again called for. I urge you to educate > yourselves to what is really going on here. Most of the information > can be found on the Web. In the past 4 months, I have found only one > small article about this issue, tucked away in the back pages of Issue > 18 of the Alternative Medicine Digest which is on the newsstands now. > > If the German and Canadian proposals are passed, it would > constitute an effective end run by the pharmaceutical companies > around the medical rights of Americans. They wouldn't dare attempt to > do this in the U.S. because there would be such a public uproar it > would never pass through congress. However, by taking the stance that > they have, the FDA WILL ACCOMPLISH ITS GOALS BY LETTING CODEX > DO ITS UNACCEPTABLE DIRTY WORK. The pharmaceutical companies > are planning a global takeover of the vitamin-herb industry and > within a few short years, they will have succeeded by pushing > competitors out of the field. They are planning to do it very quietly > and carefully through GATT and the Codex Commission. They will > succeed if they are not exposed and their plan is not given national > headlines. > > This is the last wake-up call that may be given before it is > too late. It is of the utmost importance that everyone become > aware and voice their displeasure with the leaders of their > respective governmental agencies. In the U.S., it is imperative > that everyone call and write to their local congressmen. Phone > the White House. Call the FDA. Tell everyone you know to do the > same. Call your local newspaper and alert them to what is really > going on here. If we don't take action now, our freedom to choose > will be taken away without most of us even being aware that it > had happened! > > - About the author - > > Jackie Buchanan has 26 years experience in the medical and > textbook publishing field. She may be reached at Buchanan > Publishing, P.O. Box 732 Collinsville, Illinois 62234 > *_____________________________________________________________* > Also see the following Internet Web Site for further explanation of > this > > activity. > > http://www.pnc.com.au/~cafmr/hammell/index.html > > > > > > A MESSAGE FOR MISSOURI AND FOR LIBERTY > > > >
------ =_NextPart_000_01BCBF85.8E713270 Content-Type: application/ms-tnef Content-Transfer-Encoding: base64
eJ8+IgEVAQaQCAAEAAAAAAABAAEAAQeQBgAIAAAA5AQAAAAAAADoAAEIgAcAGAAAAElQTS5NaWNy b3NvZnQgTWFpbC5Ob3RlADEIAQgABQAEAAAAAAAAAAAAAQkABAACAAAAAAAAAAEFgAMADgAAAM0H CQAMAA4ACQA5AAUAPgEBIIADAA4AAADNBwkADAAOAAkAOQAFAD4BAQmAAQAhAAAAOEZGNzMxQjFB NzJCRDExMUI4OUEwMDgwNUZFMjdEQUUARAcBBIABADwAAABGVzogQ29kZXggQWxpbWVudGFyaXVz IC0gQSBQbGFuIFRvIEJhbiBBbGwgRm9vZCBTdXBwbGVtZW50cwAGFAENgAQAAgAAAAIAAgABA5AG APQqAAAwAAAAAwA2AAAAAAADAACACCAGAAAAAADAAAAAAAAARgAAAABShQAAZg0AAB4AAYAIIAYA AAAAAMAAAAAAAABGAAAAAFSFAAABAAAABAAAADguMAADAAKACCAGAAAAAADAAAAAAAAARgAAAAAB hQAAAAAAAAsAA4AIIAYAAAAAAMAAAAAAAABGAAAAAAOFAAAAAAAACwAEgAggBgAAAAAAwAAAAAAA AEYAAAAADoUAAAAAAAADAAWACCAGAAAAAADAAAAAAAAARgAAAAAQhQAAAAAAAAMABoAIIAYAAAAA AMAAAAAAAABGAAAAABGFAAAAAAAAAwAHgAggBgAAAAAAwAAAAAAAAEYAAAAAGIUAAAAAAAAeAAiA CCAGAAAAAADAAAAAAAAARgAAAAA2hQAAAQAAAAEAAAAAAAAAHgAJgAggBgAAAAAAwAAAAAAAAEYA AAAAN4UAAAEAAAABAAAAAAAAAB4ACoAIIAYAAAAAAMAAAAAAAABGAAAAADiFAAABAAAAAQAAAAAA AAACAQkQAQAAAGglAABkJQAANkgAAExaRnXquT8rAwAKAHJjcGcxMjXSMgD7MzYB6CACpAPjCQIA Y2gKwHNldDAeIAcTAoMAUBBfVGFoXwNxAoMOUAPVEWgzEhdwaHJxMhFWfQqACMgg9jsJbw4wNRdf CmACgAqBbHVjAFALA2MAQQtgbrkOEDAzFRELxBMgaAQAgiAcIXVuZXhwBZB6dAmAIABwHRAE8ArA eaIsBpAgdHIKUC4eQP8KogqECoQLMAzQAcEaoQLRkDEgLS0edFJ1BBC0ZWwDIFccEAGQawSQUR50 V2ViAMBzHPByUiwRUGxwEOBCCQB4EiAIUHJwBbBhdGlXAiAedRqydQMgaAJAcNA6Ly93JZAuB0Aj EcsCYCNgLgWgbS8f4yTw+wFAHoM9J58oah7aGrAT4aEV4CJMaXYLgGccQIkDoGEgBuBva3MTUHJw HEJsaSGwLCEq2HfdCsBlE1Ag8Cxgbx3gHKH7CQAAkHYHkB5lG/EuUCxgXyuwISAugR0gGMAgI+Bu ZyGwHRAD8HRoHfAvoCCzBGAikCBmCHEtkSAmcf5iIPAkAAJgB5ErITERLsWqdwWwbB0QLTEDYiPg jwuABCAt4QeAbi4iNBH8Q2gFECKQK9AvoAXBM9GcZXkf5R7aFQMxNh52XwNgHPAc4CBROVFPBRBn DwuAB0AF0AeQc2FnZT85UzhsJyMLMTjkAgBpLfgxNDQBQCwwPPMM0DzzqGIgRgNhOgyDYhFAGEZE VgBwBxBkb3kMQGEG8CZiIFtTTchUUDo/H21dHnU+IM8GYAIwPogFEGRhHbAGUT0FMGUG0DYxDiAi 0DE5RDk3REAxOjMV4U05QddUbz6HIO9B53Vixmoc0T6Id2Q6I4EBAN8jcCLwB3ECMArAaTHxNCCY QSBQGvFF4SBCA5G7IvADIEYrgB0QSDBwC1D/Q/BCcRCgOw88GSo0C9Qeie85U1B+HnRL8HItQQEA HRB/B4E6Yj6AUZQ+Vi4AA/BuMT+wY20uBbArAChFcVQRIEguS2EEoBEgdN4pHnRCYQSBU6RNBAEI Yl5fKrBEEUpCAHFAOmBmpx4wENBD8C5tVxUuCYDHDHAglEPAbHktNfBWr/9Xv1jPHoNF9Vr/XA9d GVTA/k0k8CQATHEwQAWQBSAIkLdMwS3RVdVEI/BS4CBEsJgtMDk84BXgMDhFAcQ6MhXgRURUHnpL Qf8REB1BK1BShR3wS1Aw4CwDjyKQItAtomcTYWRkGMD/BBBS9QRgIwBf/1lqZWwmcVUDgWQEICgs MyIvoXDrNWAFsSIcgHNIQATyRBBzXp9foyIpZtQzRREQcv8ugAXAMOAj8CUQMWEEIGcf+2gvAMFq BbA/gARgaX9qj/8vEEg3LtR3xUmPSp9Lo0xP73fCY1N3bBwAdURxIEBDsRljoSAyRPAB0Do1M30g UDAPQCcld8E+RHd7QukJ8CAmS6J5BdBoUSNh8jwHQG1AdQEEkDGgP+PmPh5+HrZEZQrBQzFmAv86 5x6SgMAJAAfgcvItMEbi/ncFEAJAgNEA0AWgHIAFQA0t4XdxQjESQ09ERf5YeJsedAhQbEAEASQX A/BvRvEHgAORZuFlcPGBUEHXB4AFEB2AbiLQQwBwaFD7X7EdI0UIcCvQi7FVQErw/4SQLbEYwGhQ HSQ18YVbi2KgUy44MzBVQFeHIf1mw3kIYSOBGxBoggOBQ5L/OfA18AXAHTIJAB2AAyAckPx3cwqw HMARACLQHTEeev8c8EbxB0ADIJHjA1CE8i6m/l+Xn5ivmb+avYNvd7d4H195L3o/e0qhT6I8QoFQ Sv0A0GsIkEtgGiAQ4DnwJDZxnDwiVW4ysQQghsAg/HB1BUAHgI1gk+IDUAngv3RhKxFwBDIRAIAk AHSmcP8kESLQMRIkAAeAd2eLUyZx/yxgiECA0aajC4CqoYtiVJH5AHBpeixgIYBG0R3gp6P/A5Ec gASBBaBw8XdnpsEBkJ+TQSuwBSAeQQEAbnkq4vhlcXU6ARWwKsEysDqA3y6gS6Nt4BDQLCBhlEAw A/8cgCB1nRGMhh0jAQCUUDjwLw3gHk2iP5znLYDBamEXdVADoEahaCLQUGh57w3RX7G0/7mOUznA HJAiwd2EgGMLYCPkLdJJVmEcwPlWYW5jM0W0nJ2flLErIe0AkG1h0iKhbb8ShoIyEf8BAC3SscEx kAWxAhAEcB5l/yFgcVEhgIeBqJCWIYFQi6L/ccGMAQDQMPAdMowjAiAtw/8x8YZzMOCPAYhxS1AI YR50/y+gB0Aw4R0yMRLHBS3ijDP/fUADgkQQKuK7oXHjC1FVkT+0jRwALGAxoKiQMCFhdvsLcAtg YgMQIYCBUJODsND/OgEikCPwMfEt4TYhbgAi0P8q0AGQt1GUsB50t0KtIWIw/2yAItC3UQSQB0Av 8WYSq8IfMREFwG3gTGcy5SBVLu+Q4JTYxdEIYGctgYh0M8N/0FFDcMlBs9G/4qthHRBi/8zhbBOH MjExaFCyMSvgLeH/PPA4VZMhJBEyAZYhHQGIk/++HyOBinYi0IhADeDIQZSB72NhMtIedKgxahyA HOC7km8wx6XAkXEdEE7Ytcd2Vz0z00jHFDmgrBMj+ShX6EhPKbSNScKRHGIEgfkxA2d1BAAtwzjV KuKmYP8CYA3gHWB0wczR0/VwKQGQ/x1ACxHhFS3SwbIdIwbg52H/ptPAsnHCiGXWw4qp1VXFsf8r gKvRHeExIaehBJEj87BC+xDhAMFlqKGT4guAWaAikP+MUXEyHnQcIu0Bh+Kq8SGgESriQUxMBgBV UFBATEVNRU5UBfAt/85COgEFsdGDA/E6kM9FzER/YeHWcRWwB5AFA7uTpdB5/bSNRc2h5YEvkR0Q KyFEkP42FeDBcjESpmAjsS20ERH/5RPs++b80OTptMF2lLHZmP+KWBxCrdIgdarBggAq4YFB7yZx +KIdEC3hR7/xjYW8AL/tGrfw7fqJ9iO3sQFPcPL4OTAl7H/tg6v12LXxMfxPV2TQZtFwZrOzzULc cv+nxWZgESAq4cBgGMD0svBS/znQDbCmgWGS+fzt3YewA1r/y4L1gqgjyQA2MQX6HEIzJ38BHODK LdKSMQ6E3oEDw07ARUlUSEVSy3AToOHe4EFUVVLxMLiEE6An8TATkCOAQVIUAElOQERVU1RSWd7g Tz0TxEfx4BOw8TCe8FVCKExJQ1UgQfIQQU7SWSCFRVAVgFPx4RQw6ElPTiLgVBPTiNTx0LJFGSBO R9MwtJxTjjH+cscBUkLWcTESAGUL/wNY/6jy/aCJ9v0tyjLDs/JwKzD+LbuhLSEz0t3wwNHycLgg /nOewAqAyNHHE+b3Q+HwUv8rIacwzHC7g60TjGDP0LJg//S70ejPNfSxLoBCgC5xqPN/HpC8QO5S jQDyulVANmFl/63SlMKMYMFxCsGOwP6W2+L/M8CCkI9yi2Lr4vP3LJRxQP8v0GbSCTIxA7tQzJDv ELtQ/zawlSNoge8QrrHY0wSlH87/DaL4stimcTM/gCXROTD/or+BQIr23hSO0zCpshJm7iH/jzDd 8zkQ6yCqgOWj3YSXFv+4hkchYeP5ILtQgjD5YnLU719wrrCl4I0ASdkRqpGHkP+OEKYB1qCl4NcR EsCHFe+V+feCOTWWoUARgXDXEHHw747At4AQ0LfATQcy2cCkEce8oEbwk1FLb2iWAY9h/k1D8zEy 05Ycx6PgVmJSsX+NALBx+AKn1NnUCTUkokLf6yAhwABkMBU+BDa0j6Wg/kHAYh1QuBWPRGIwKEIs 8NeIMUtQ2VZijwFr5kbctv+5g861OhfbtbNi0KGmwpGB/8cBX3CukTpB+SA7onTQleD3uInCse/z Y8kAQYCH4aAQ//CSZsNoVXHUv4GTUOdhpoH/PuEBQLRnuYM/MTvA+SCsYt+o9D7ho4ExT/2ZYbiJ s+L/3EPC0hxmHV+/kOlBCJTktfu4ifgxaT0R4AMiU3NA5oD91UFybODCwc1gzwHCwJMh844AwyNl ZnTQ5QFw8FSK/49hCsDEIWkwzAJgUHRB9DP/0emOcTszK5HgEIxgTzHL4f/MkPlyoKr4Mo4QOfEE pRzv/6bT+3N1ER3/uInd8tKlMc//4LC8kclBwXHs0nHUvKCeQP2OAHmUwbiJZz9oTwzaO6H0Lkcq UEYvkZMQzzW5g/9BgDvjknFR4bgg9EL39ggg/z9xzfM4AJXwMQaOMI4gOfG/lOe5g6gysBGeMYFB dz8xv08xAJF4kPdG2CAcZk7L8dZuQYH5gFT1AGKH0HBkX7iJlFDMsaeUn4B5utJC7RfARpTDF6Bv XHB1kMqA99/g3gZRUHJ60cLAINRB1v9l528/Wxyo9PSxrqP0Qo1g/yRh/cOAj4fQlCC8oKYAL/H/ j0P0sVPxy/J1U3W/dsRla7l7kXZvImD0MipQSVbP/1fYQHGmMMeRxlHOcO8QsYD/LzO4iU42u5VO 29ZiMIfxAfc3EIaSLsJupnA9QfopfHT/oBjQUWIi6hH3gffQiIV2pv3U4y0iU6olKFGSgGDKLtH/ psDXQMiUfZC7UD50h1hO1PdWRNDkMKFvXuA4xrmDfxL70qWrcHgKQXrg3EK7kgKwf8ThHwQshZEh CtEkoq3SIPgzMDC4iZWHh2yUiySx/9FC1KO7UHWkCoDw4XdKrvD3sODRkq9hIkc6wmCq4U/B/12A X3HF8dly/aA7ouwxVpD3wrHd88CAZx6QoEL5Acch/7bgskEtAbvw3NU7+iHBO0T9JKJJhrB4YNgB BJbaIe0V3y6hQVBOYdYhuIREuqCRMf8q8Qmz7PHoQqzK6hPBgLqgvwsBYAIpABvC90QP51fRQnZT 7xAvEkrGcQWzIcBB80OxQPAyNbrwRuPLcxwCl9pAxPGogyLLgXknJOB9R5RTSZSoIOWwp7TCwFN3 5DDSccuBbX3B1HHAgCSgMS40LUKVlUTHEf3+AkI81JUCuNlswKbQy3PvrQbcIdY1OEB5OqTCgtfw +7tgZNFkeLEsRCu2G8D+Yf8oEVvAjULWcT5g7sEJ0Afh//BSLwBOYkDw2gDcMdJxsoD/6PEvEIHh 5XL3JUH4tYcEtH5BEqFOcSHAr4MRIUhQc65vSPEPZCHASgqAdYbS/z4zwceAMdYxO6DIFw5Wn1G9 3gR5PFAiYFwi9EFtn1aPLoM4QCrA04UkMzV6IP+VhrtgmXMksV5j6qAs8DjO/0fxfoCNQCrD+DTl guf3Our/Lho9MFxwXuB3SrtlL7CVpN91UUDw/BK6ggCRdTcBh6J/fbLokLqRa+FbkW5BjkxC/5Ky 9yDtzftUXmIs8GIicND/X0ENpMD0NBBRUblh1qsy8Pp3G6B58DBLQSJgO6BNleeXgWZxPIA4NASH FeDNZ//ENBDioPpexejh/hHu8L+E/jiVd8gWlIGWcZthN+Bzkf+896CwR5ny40pQjTESwEOx/zci 3aPR/7cj8MFBlODYqxG3qCT5oTxQZGHQ90Y15pD7PzFYanPg8glROCAqwYT1/+NXMvAdgJ7RqxHF Mp7gBCI/xXJHmSTgeFBdgBxIRkT2QS7CrdBiOACAATxQxNH/W1C3sXBDMLERIWKwVmBy6v+3sF7g 6eXrJAbAIcBDEKvA/z1x38FeVHTSQxNZwWCszXXblIDg5yc8gEyAZ9jAtZD5PIBVLhqwqsJb0S6D xXT/XETWq7+yN/CmYZGjPID+UO+L0O+zXCD6czqDlg6BJpT/M8OOTFtiCVM7oOpTJhHq2P82szRC L7B+kPTRLZA8wCdx/02FLwAg8VyrBJSG8QeVhFD/yUByoQKBcKFPcFfgiIEkMf8CgzcAX3EMBE2A QGHK10fzx+Dn63+3I0pBTfXQwPT/XDHPUZ8UA7o9MJLwkcHlsttKAe/CYrWQLzFvd1qkEv9OAnCh LtH9ej6AVZFetV5w/TKxRSgxlmJPgmYywPNqKt3OmGp2wXKQTmB6v4HaE94nu3MH8bv0e4B5IaC7 MZ+Q8UXl/gDbOn3xLUFyUf/TEZjBSoTA8/4BdDPYwOF2X7KAURIqwCzwv4EktpAw/iyg0KDqLtGo IHugbLJmM+9NFk/iFDWp4D+6InjSGPPvILTY4kBggJot7hA34LfR/+n0lQPaFAo1H6KZEwHEmKP/ SYCD8o4uwPR+QoRgyVCpgvcSUdP4bIBRunF/gTzAZGL/O6BJhbmhjnpMgMPhJBLs4b08gmKbQnVh W/Q1sXJMgP/AI3+BBbSvM4QAngAPrvoQn+n0YhPWYX/ijUBiLVfg71mRPTU+dLtgQ3lQTlGB0v+K wLFTR5TCshQ14KKLxJcj/2JhXHE4pKohfpCkwQRR9gGrVmBcYDoPv0nQkE9ggP/OENNiRuJPoESG oCNFkk+g/0XlkkLs0rDwTlNQGt5BkbD/W9FrFV5w/zL+UNNR9zCRsX+Y0VZgymGT6dijhMBRcXL/ J5mvEsyR3pT2kqyQ3SKP4f+qQHVhkTHMcmzArwAN4ZTT/6yQYMrcoJbxekWBlcPgYuB7XzCPkyhV goOkSKK/gUT1jzBmXwBHunBM4bfBZXrf2LKwYEVEumCUBynllnOg/2UiIKW/hH6FfcF9gmDdfeL/ 3pOQwQryZjLtoRdB0VVbhv/YscQx4YGn0Y5Meri0wPOgP3tR3SJ5ETJAw9HDAElH/3J22SuFPzky yUDQkE0g5fXhecFOYXppSdTiEY+E/XPBcEgT5eHl4QfCjkyoJO+S0KwxBHbjIE4hg8Vzt7H/1pH2 8UrReKKp4l9DpJF3Wu+SsHEAe6FIEU8iEXRj2tTf9PDFsXGBkMHl4SKmsZJR/yuRAwHv7OVxj+Gx Qa70kvLvPUJ3MBshkjNnTyKkRJaC//4BqkCNMFKC2LCL0CeZpVH/5hC1IIb0MtMAM0PTmrGq8P+I M8yHD6s4sbDy2MBGMjhS/64gj1A70X/SnwEAMLMjhlD/h2AMpMlAf7CGkakQC8AnlH+wcChws8El 4Z8SpTALIiH/PbpIQ4If2qIyM7+BSIgVc//YskPi2LCNElKBPa27kFmAfxZAwrCbMGchlJG3wY8w bJupEKaBYqkQpmBjLqkQ/8hiC8ABcc6x2LEnmfaD8hD3y3D74fEwKAOxGEE9Ya9B/1HQfMSPMMJA emK38l5B627+Mn7BmlLI8aIxK7H/QYD67w0CAmIc4AqFbW/xCyOL8K8xkNarXcUDEWNwMCjfUP/P MJ4AUdCyQNNQ3TFrEvVF/3rRDIAMUS6yYOMJXsBEzIb/rFF2wWzjRS/aQZcjgTG3sO/2URHyFLpD 01L1wYxEApT93KB4DHDfgJM02KN/FQKw3ChWfyQ/0KsRNqDqpQDWZ2eAl6ZFqxExysCZQX+AdFHQ USllYxRirNGU4iifvkCZUJiKetBZwHp5rDH4UTEwUdDVpIExobFNEf+kMT0xDgILwHqQ5hEKlNWk v7MhmIqgUQGR6x8n0jNngP8/5IdgbTAMoUfi2KORj5KS/57VopKhu8NxBgNPUWciBfL/Q9NPkHqQ wkAvQaCDzSJDtXdBEH/DmIpBSVFF82tCVB8kwHTB3URacEvCKEdB/FRUUdDAU7Mh6mACske074q7 n+IlojzRd9CQbGdgxf+E0EXQV7Iy0bTSRq96wfpA9/eRPMLi1U758nAwR7Qp5f88sgszkPEEEEPS SuvzUTrwf2xoksZxgcKwZUEjwfUYV7dt4q5ErApPWgBXkXpNNfhXVE9R0GnjM3aLs0fQ/9iFZvGz IhNgrAowEt4RaRB/PwHtFGMzR7QW8aKBKHBt+nkPrTT58XyBuYOmT4Ex/1sRu4L6QP8xJlNwMP5Q VpL5/oBnaIq+P+SzERHBeqH3ABGRAmeARjRyIhFgoNX0/wiAhVHfIfPNMbPQkEO1P+T/yvVrQPOC XdMNQiUQOvBUQLskwEgRUkXxtC44t0I7gvhDLTfhhRQC0EHmIoOjPnV1k5fyPEQCodNgOD//rAre swxz2/FwMOLFyvUY1X8AUDbBL7FwU22kqKKhvHT/DfBYhM7ISLXZ9ji3DKCvsd/l4jGAx0HENoJE VgtAUoL770ENMHYnAWtRS8B74Kl3v0x1SIhj9qwKRJJYYWx/UdFaECgxNkZTMjiATSD/l1FAY0Pi NnBisTbF4PAAQH4pVaPRy87rYTM6UQ1gU//L4ct07hFYAQiAvfYNgvug/zJAAECdLEoDM3YmsABQ MEL/JQGG8k+QZ4A+wdvAFkDQ0/c/xrUhGmFqA/GsCjhD6oP3mlAWMuqSOCOG65EkI2kR/wPB95H7 4YWf75Njkv7RGNT+RpyhIZLMhrViFhOgkm0w/0SwN9B8gDiQMcCDImziJ5T/cAB74EPToJLYJGkR RalIJP9iiXggoFJjAnV0J5TegAry/9gkaJFKwPmAFfGcIBJSgxMfQ4EUAkO1epD7lEVTU/hJQUNo QyeUgDLAFJYg//nCY0JjQJ8COBEkhnZSQIDzJBU/gDIwFvGq4ieUilLfn2E3ARKCcbBDk2NZoKiz /1RAFCB4IJVAKlEJdoDxShH/y2Fz8XXgSYEvoSeUX6JoVb/59v5VllHI4HUxr+YtquB7roEocS27 EIhwCITg8Gz3emGwRsJwby3ARdB6MQi1/+Bl15EckpvBSsBKVLMRdZH/u5FjVfn1DFU3wlKCL2A3 8f/CkS1CfGIzdWiRciFJUY4w/0YB2ef3gUgkAKEnlAjEdvD/AuTp1g9yZUG7AOYQdiAuQN9pIRLh QVJX8kgRRYOx0TH/JrBikH9hESXYYVcJ1UoTkv+x0fiyQ/IOgmzjfPQEhGPx//qWBgB2QsqBb+Av 8OBynEL/dmGgESSFuxCVwk0gX2Aokf9LwK30QIFxhD4UiOP68e9TP8Vi2CNhARGJQIE/gDg5ui0/ gTA0/j7BP4Ey9yj/TsAPgdoUrZBKwEuwP9BPYVuFIUCBS3UTWjBzqxFn/8JwjnNhxfeCFFJDcNoS Y1GbTrBngFchs3bwTUQBo/9ZwE0gMSIB9o3xRLAGoWtRf0ZhUnB3oD4UHJFM8V7yauvCURyjIqLj Ik2A06UT4/9ckXWTlwbn47Li9SN3NWuS31xxWDJlgiz2SQMx04BxhfsoKUByVEAQ99JSAbfQhKHz T6VAgU9rdiAuAnbwRaj/XCluk3ow0yAWIUOEIGBPYP9GYVegP4BY5L2gTRBfoNnU/y9Y2dQ+I7lw nDAWEmwSZUD+LeEAULBrkVNAh4J6kVjk/7dwwmR6MHDQx+T20PcArLH/5hH3I/+hAbKv5nqifHKz kv/1I1z3g6FQ8F+gHNJrofTR917kg4FpEHIl4BeXIbgmIP9ksGhVsdFY5FPAXiABcic393xRh2Bn gEwWlRPTJiDTIPcUgkTBXHB4+LS782Dw7Kb+SADRxxG71BMHRLMGkuXzf/coAbJ8sTqScJF7UmtB Zv0rJUFhgmEBlUBjAmLy0xMISC5SZ4AzNjQy4C9TMjEzmlABtY3j/xahlXFEwWQwwOeDkaXA29D/ e6L1QHzRfvHgReZScJHeYt849ahwfIGhJMwzZ8uRznP/MEiLdBPRcIOJRDwb7COlz39vtwxlnDFr UYkwBnHLM0n/jVBhSXwhbRFiBpZAYyufc//+9nIhJFFooQYALTC/4MfD/wXlduECgPQiFwLRcQYA yGH/JCR0ERcCjMH/Bbriu0SXccAkMjUwLDBxoFahn2aSy5APgNUBrfQkMXGS93GWetSHsSkVpZv2 +HLrgPtI6nnQZfsQNmG1xu3gk4L/6oDskSmVOWrZ9MizlbFjY/5mItAN4j6QNNHTkUzxu8T/OEFQ stoTT9IeYO3gkGEMVf9AcET0GJCzwuyBbPEBo6Egf+Cx4QHyQIqB8mHCwVCUIfv1nyrhNfcofwHR cLhA+LT8cXVlgTgxiTKEAVjwODH/t3CVsAGwoQEHl/tJHTLX8P+qQcLBNZFsYMiwLoRm4ZCR/2Zw vhW3w8yU/xXKc7uQvrD/lsL5Epfx0sE04EhACtP08P9Y4QrTXvK+5tMhaDMrlDkT/2jKrdDCUUaS HTJHlQsAyiD/v+Fm4G3B5vF2wX8A07ErlPhwaHnXcO6gQHBtwdPQ/06A+xABIpETmsILm8gExzG9 LWNvMyBJcgsAbuB0HsffToGqEEZS7rNm4HVlca3030eRiNmWphby2dFmFrEO0b+vkNrGzDC6ILmx H3FnNmD/CwBAYTMTY8EAYPERTlSs0P+1MVM0TaHUwoKoGgZE9EzJ+z6RQaMokxAGACYgBqAQ0f9H AXPoFvNGywEU9TJSUxOh/9CQJ5CvFO2QODH7RNUBRrH/dRE7lI2DxkILAGWAKyVl8P+9sExR7BQ2 srmwdSHG1K9zf4sD8lKWwb8WToGFgSstTr+x0AsASYTMYf+hKmM504BJFwJCWbZgTEy2YFCAUEVB UkFOQwLg3/crUDXMsNRyTlRlWTALsf8iBE9ihXPIwE6ftNJQDzVw/2eCJ2RRtP0hToG/oCVg2bD/ OsRDQZySIiXpAyNHllCckf/pwyOhTTX3Q9SA7cDAEdFA92Hwy9HhE0/CYdGRO+BzIO+CQyuU6yAw olC45JpReAFPu1QLANOku/NzOis8Iv9okSmC2GE6ImZxKTa41WPB/xnwHKP3RmPB7YGswflgESb/ ohTuoJJRKkM6I0o3uygBMv84YUGyBOPUUZGhPoXmU9eA//yF4bK78meQ4QAcMIrCOTD/9UPN4Cs6 oIfCV/0i8KDkkP2b4HBAE4bjyC+7RMpVk9Hf1LFIY/8VMyDfAHkHUWPw/zZQ7tG+QDYCYgHpw9RB vQK/laKEgomUhYFtwWH0YQOV/w6BauFewyWwVYLeQR8j0E3/hTH8sGbgmLO7RM3vzv5UYP8T4wWx b+Fs0dFP0lXpMJGl/xgCy+I5ienBXMEhMKkjaKH/WvLWF6ty+RFNVu8AAJEGov+FUdsnuszcTfZx 7YEGcLzx/+32t1Hq8bvz/LO3RU5Uw4T/E0Pw4fyBGhU6005UPpD9kv/6BX9yCFHuYhfHxmIXgrjV /3chNNFGMZwGanPU0wdTRBD/QcSKwV0AAUFBETwmgDQOwv/UxmeQSCD/BkkS/ZK6Rhti/1cDSrNN QVgxaHGLcKoRCeD/qzDE0yRRvBErlPkB/YA1kP/TYxOxBPI5MajBOCJu4BeC95pRSYIZkE2SAXcW QfAdcv+JI7JV2bGrgVgwnwKaUlQyb3vAaHG8dO2jNEBQxkFo/23BCjBpI/9GODFMgamVfqP/x1M2 Yeq24oIYgMaQsYEkYP9PcBSRhYK8ZVjTPpAzIKhj5kkFEiuUMTh3Fijw34Xtj8FNRtImckQOgE0R wRX3OTH/pSEwdxiAuzIbgyst+kl3NEcWwEBhFvMgY5Nx/yQSarBaQHKiSaHtobLh4zT/qzJrt9tx zNFdIrNy1WQZ4v+1AJVQVWaiv3QVeSWe5FWj90bUtQZ3IUE0AUbxzcEwAvOFoasybie3kLthN7GD RM9jsUc2BKW8dFUuSNFdgP9HAIuCSXWrNmXwN1H012YA/57gbXAkseyVqzMhMExBD+P/ebdsEZ7Q aENVEGrQTEHWof9VgbRA6Sa7IuWi+zGGB5YQE2kisYhXSbCiQ0NPQE1QTElTSGiAVDpTDcBPsJAl 0LBhTEUgVFRJTke6YE9EJEVYK5RETyWjVU7BJQFFUFRBQiaAMaAISVJUsHBXT1JL3y/zE78UznaR YFBufVBBEf8uMJ0gvkCn0bQyiuG9w4Zi9ThlLUURYmaXoHh08kHx+9sQkBB3qwLHYPjwbWFtwf98 A+ODaSMdAeWgvOFdYc0h/4uARCJrtnsQ4dFHw2eFhmL/cODe4NwwGBQr22PBhUHjUX9MQoP2eShR snqxpzN55Ef+QSagZSP2qLpwXMHKwWwg/xgGWvGpljLTjgB3MzZkiZL/uqAPQVMl7UUsIQriiZJh 9PtKNnAnZFYQaDEMfWCjwxX3YFAKYrRBLWYASrX7MlLg/+RTYfRdgFgxr4HC8sa2ayH/x8Focwry dzRnkAFA7cHL0f+VISKXboBMRhuR20F5JWyR710kfFNORWVwc+GxWAC2EP9/Qe0Fb9GKEFJSdySY AF3W700wEmVu4B9Rbojj7tHUQv/KIQBHG0LjM+KDh3C9ENWC74YGSjpE82Uyd9lB5bOX1N+b4KNk IIRmUVtgUKsgAvb//9NaAMfRIQCLgVtgDoBFE9+xw7hR7rJKZ/kCawxBN0X/YlcPYBeAWUX6QlZl C5LiMP9TMWUjfrCl8OrzalH7DsJU//wdDWGvMYBgGMK0NHjTDDL/jTG2EYAmxgKrID7x7JZ+wv/F YbRB2AGFhjUSSRN3IYuA/0pS/vIsY0vDpsMeVgHgj4J7irDj4WSBPWtfbAi/cEG/6sZ6MDUgMQFt AMH6SozSPYbAQh0RnYH8ge7xMjb/MUQ+sukB5YO8ZRZWoIeVgHx4dLdgeJHUwzOjNbZT/xYiRaSo wdMgPxK3kG+GwlRGUHO3k7BQLk+4UELib/cgNzMyumFdIPZRP81w9/EBoXiy/CCZQDYyyDIzNMJU Kl96z3vf23zvfYcqwlQI0HOFUIaw/8VkRoCrwqzSgiDfgqygAAL/wGBVootCOYDHYNjCPsEsIR+J JMP13HvJxK2cXGNmHDFcq0CyEKywcDovpC93hoAucEnQLuGBEi4bwC9+pMBmbXJuLwHg4sDusS8v AbqgLq0XAG2k4IWgMoXRMITbj4n/fqUJgLFgU0FHKNAORilgCYAlcFNPVVKb+JCxMESMUyVgQkUp EVeKr8JGwlR94mAAkFADACYAAAAAAAMALgAAAAAACwACAAEAAAAeAHAAAQAAADgAAABDb2RleCBB bGltZW50YXJpdXMgLSBBIFBsYW4gVG8gQmFuIEFsbCBGb29kIFN1cHBsZW1lbnRzAAIBcQABAAAA GwAAAAG8v6nJ/j1M6t8qvhHRuJoAgF/ifa4ABWQc8AALABcMAAAAAAMAXUAAAAAAQAA5AHA4CjnA v7wBAwDxPwkEAAAeADFAAQAAAAoAAABSV0hJVEFLRVIAAAADABpAAAAAAB4AMEABAAAACgAAAFJX SElUQUtFUgAAAAMAGUAAAAAAAwD9P+QEAAADAIAQ/////wIBRwABAAAAKwAAAGM9VVM7YT0gO3A9 YWxwaGFibG94O2w9SFEtOTcwOTEyMjEwOTU3Wi00NQAAAgH5PwEAAABKAAAAAAAAANynQMjAQhAa tLkIACsv4YIBAAAAAAAAAC9PPUFMUEhBQkxPWC9PVT1IUS9DTj1SRUNJUElFTlRTL0NOPVJXSElU QUtFUgAAAB4A+D8BAAAAEQAAAFJ1c3NlbGwgV2hpdGFrZXIAAAAAHgA4QAEAAAAKAAAAUldISVRB S0VSAAAAAgH7PwEAAABKAAAAAAAAANynQMjAQhAatLkIACsv4YIBAAAAAAAAAC9PPUFMUEhBQkxP WC9PVT1IUS9DTj1SRUNJUElFTlRTL0NOPVJXSElUQUtFUgAAAB4A+j8BAAAAEQAAAFJ1c3NlbGwg V2hpdGFrZXIAAAAAHgA5QAEAAAAKAAAAUldISVRBS0VSAAAAQAAHMEAd+BC/v7wBQAAIMCDFeTnA v7wBHgA9AAEAAAAFAAAARlc6IAAAAAAeAB0OAQAAADgAAABDb2RleCBBbGltZW50YXJpdXMgLSBB IFBsYW4gVG8gQmFuIEFsbCBGb29kIFN1cHBsZW1lbnRzAB4ANRABAAAAOgAAADxDMEY1RTI4RjhB OEREMDExQjg2MTAwODA1RkUyN0RBRTI2M0RCRUBocS5hbHBoYWJsb3guY29tPgAAAAsAKQAAAAAA CwAjAAAAAAADAAYQB6RAQgMABxAOMgAAAwAQEAAAAAADABEQBAAAAB4ACBABAAAAZQAAAFRISVNJ U1VORVhQRUNURURBTkRTQ0FSWSxJRlRSVUUtLVJVU1NFTExXSElUQUtFUldFQk1BU1RFUixBTFBI QUJMT1hDT1JQT1JBVElPTkhUVFA6Ly9XV1dBTFBIQUJMT1hDT00AAAAAAgF/AAEAAAA6AAAAPEMw RjVFMjhGOEE4REQwMTFCODYxMDA4MDVGRTI3REFFMjYzREJFQGhxLmFscGhhYmxveC5jb20+AAAA wq8=
------ =_NextPart_000_01BCBF85.8E713270--